chr9-5467955-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_014143.4(CD274):c.*93G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.544 in 1,092,952 control chromosomes in the GnomAD database, including 165,687 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.56 ( 24547 hom., cov: 30)
Exomes 𝑓: 0.54 ( 141140 hom. )
Consequence
CD274
NM_014143.4 3_prime_UTR
NM_014143.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.710
Genes affected
CD274 (HGNC:17635): (CD274 molecule) This gene encodes an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. The encoded protein is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human malignancies, including colon cancer and renal cell carcinoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 9-5467955-G-A is Benign according to our data. Variant chr9-5467955-G-A is described in ClinVar as [Benign]. Clinvar id is 1251725.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.784 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD274 | NM_014143.4 | c.*93G>A | 3_prime_UTR_variant | 7/7 | ENST00000381577.4 | NP_054862.1 | ||
LOC124902114 | XR_007061406.1 | n.256-8768C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD274 | ENST00000381577.4 | c.*93G>A | 3_prime_UTR_variant | 7/7 | 1 | NM_014143.4 | ENSP00000370989 | P1 | ||
ENST00000661858.1 | n.277-8768C>T | intron_variant, non_coding_transcript_variant | ||||||||
CD274 | ENST00000381573.8 | c.*93G>A | 3_prime_UTR_variant | 6/6 | 5 | ENSP00000370985 |
Frequencies
GnomAD3 genomes AF: 0.564 AC: 85540AN: 151754Hom.: 24528 Cov.: 30
GnomAD3 genomes
AF:
AC:
85540
AN:
151754
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.540 AC: 508465AN: 941080Hom.: 141140 Cov.: 12 AF XY: 0.542 AC XY: 265139AN XY: 489406
GnomAD4 exome
AF:
AC:
508465
AN:
941080
Hom.:
Cov.:
12
AF XY:
AC XY:
265139
AN XY:
489406
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.564 AC: 85604AN: 151872Hom.: 24547 Cov.: 30 AF XY: 0.565 AC XY: 41912AN XY: 74208
GnomAD4 genome
AF:
AC:
85604
AN:
151872
Hom.:
Cov.:
30
AF XY:
AC XY:
41912
AN XY:
74208
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2436
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 17, 2020 | This variant is associated with the following publications: (PMID: 28677815) - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at